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57 ABSTRACT 
Process for enriching the concentration of an enantiomer (or 
a diastereomer) in a mixture of optically active isomers. The 
process includes preparing a solution containing the mixture 
of the optically active isomers and a chiral collector in which 
the chiral collector and the enantiomer (or diastereomer) are 
associated with each other. A gas is bubbled through a pool 
of the solution to form a foam, the surfaces of the bubbles 
in the foam having the chiral collector and the enantiomer 
(or diastereomer) preferentially adsorbed thereto so that the 
concentration ratio of the optically active isomers at said 
bubble surfaces differs from that in the bulk of the pool. The 
foam is moved vertically through a column above the pool 
such that during said movement at least a portion of the 
bubbles comprising the foam break thereby allowing liquid 
to drain toward the pool to provide an internal reflux within 
the column. 
17 Claims, 5 Drawing Sheets 
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1. 
STEREOSELECTIVE ADSORPTIVE BUBBLE 
PROCESS 
BACKGROUND OF THE INVENTION 
The present invention relates, in general, to a process for 
separating optical isomers, i.e., the enantiomers and diaste 
reomers of a compound, and in particular, to a process and 
apparatus for separating the optical isomers by an adsorptive 
bubble technique. 
Approximately 35% of all pharmaceutical products and 
agrochemicals (pesticides, herbicides, etc.) are racemic mix 
tures. In many instances, one of the isomers present in these 
mixtures have undesired effects and limit the overall effec 
tiveness of the active species. For example, one of the 
isomers may present toxicity concerns, biodistribution 
problems, altered metabolism, and unwanted interactions. 
Various techniques have been proposed to separate the 
enantiomers present in these racemic mixtures. According to 
one of these techniques, a diastereomeric derivative or 
complex of the racemate with a pure chiral molecule 
(selector) is prepared and this mixture is recrystallized 
several times. Although this technique works well for some 
mixtures, it tends to be tedious, time consuming and has 
narrow applicability. Also, it requires one additional sepa 
ration step; the chiral selector (used to achieve the 
separation) must be removed from the final product. 
Another technique which has been proposed to separate 
the enantiomers present in these racemic mixtures is bio 
logical or enzymatic resolution. In this technique, microor 
ganisms or enzymes are used which preferentially degrade 
or react with one enantiomer of a racemate. Although 
selective, this approach is practical with only a limited 
number of compounds where the appropriate enzymes are 
available. 
Differential complexation of a variety of isomers by an 
immobilized chiral stationary phase has also been proposed 
for separating enantiomers from a racemic mixture. See, for 
example, Armstrong, Analytical Chemistry, 59:84a-91a 
(Jan. 1987) and Armstrong et al., Science, 232:1132-1135 
(1986). In these articles, the use of immobilized 
B-cyclodextrin and several other chiral stationary phases is 
reported for the enrichment of numerous compounds from 
such clinically useful classes as 3-blockers, calcium-channel 
blockers, sedative hypnotics, antihistamines, 
anticonvulsants, diuretics, and synthetic opiates. Although 
this approach has applicability for a wide range of 
compounds, especially for analytical-scale separations, 
effective scale-up to relatively large amounts (i.e., industrial 
scale) is difficult, sensitive and expensive and requires 
trained personnel. 
SUMMARY OF THE INVENTION 
Among the objects of the invention, therefore, is the 
provision of a process which may be used to separate optical 
isomers, including, for example, optical isomers of com 
mercial importance in the fields of pharmaceuticals, 
pesticides, herbicides, fragrance components and clinical 
analysis; the provision of such a process which may be used 
to enrich such isomers in relatively large-scale; the provision 
of such a process which is relatively cost-effective; the 
provision of such a process which has relatively wide-scale 
applicability; and the provision of an apparatus in which the 
enrichment or separation may be carried out. 
Briefly, therefore, the present invention is directed to an 












prises forming a solution containing a mixture of optically 
active isomers and a chiral collector, with the chiral collector 
being a compound having a chiral center and a structure 
capable of interacting with an enantiomer or diastereomer of 
the optical isomer mixture. A gas is bubbled through a pool 
of the solution to form bubbles with the surfaces of the 
bubbles having the chiral collector and the enantiomer or 
diastereomer preferentially adsorbed thereto so that the 
concentration ratio of the optically active isomers at said 
bubble surface differs from that in the bulk of the pool. The 
bubbles are allowed to move vertically through the gas 
space above the upper surface of the pool and they are 
thereafter collapsed to form a liquid fraction which is 
separate from the pool. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a schematic view of a laboratory-scale apparatus 
for adsorptive bubble separation of optical isomers in accor 
dance with the present invention. 
FIG. 2 is a LC chromatogram showing the enantiomeric 
enrichment of D-N-t-BOC-phenylalanine (i.e., the second 
peakin both chromatograms) using (a) a 25 or (b) a 40 cm 
long foam column as described in the Example. The experi 
ment was carried out at 4° C. using permethyl-3- 
cyclodextrin as the chiral collector, under total reflux con 
ditions. The analytical LC chiral separations were done on a 
Cyclobond I-RSP column (see Table 1 for conditions). 
FIG. 3 is a series of LC chromatograms: (A) separation of 
racemic warfarin starting material, (B) foam enriched prod 
uct using permethyl-3-cyclodextrin as a chiral collector, and 
(C) foam-enriched product using heptakis(2,6-di-O-methyl) 
-B-cyclodextrin as a chiral collector as described in the 
Example. Experiments B and C were done at room tem 
perature using a 25 cm long packed foam column. The 
analytical separations were done on a Cyclobond I HPLC 
column (see Table 1 for conditions). 
FIG. 4 shows the effect of reflux equilibration time and 
concentration of the chiral collector on the enantiomeric 
enrichment of D-N-t-BOC-phenylalanine as described in the 
Example. Each curve represents a different concentration of 
the permethyl-B-cyclodextrin chiral collector: (a) 1%, (b) 
0.1%, (c) 0.01%, and (d) 0.05%. Experiments were done at 
room temperature using a 25 cm long packed foam column. 
The chiral collector was permethyl-3-cyclodextrin. 
FIG. 5 shows pH dependance for the enantiomeric enrich 
ment of N-t-BOC-phenylalanine as described in the 
Example. The buffer was 0.01% triethylammonium acetate. 
DETALED DESCRIPTION OF THE 
INVENTION 
In accordance with the present invention, it has been 
discovered that effective and efficient separation of optical 
isomers can be carried out by adsorptive bubble separation 
techniques. Either foam fractionation, bubble fractionation, 
or tandem bubble and foam fractionation systems can be 
effectively utilized in the process of the present invention. 
It will be understood by those skilled in the art that the 
method of invention is useful for enriching and concentrat 
ing optical isomers and that in many practical applications 
complete quantitative isolation of one optical isomer may 
not be a practical necessity. Thus, the terms "separation” and 
“separating” are used herein in their accepted sense of 
enrichment by modification of the optical isomer concen 
tration ratio and do not necessarily imply quantitative iso 
lation. Whatever the degree of separation desired, the pro 
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cess of the present invention provides an effective means to 
achieve it. Furthermore, although the optical isomers present 
in the mixture may be enantiomers or diastereomers, other 
facile techniques for separating diastereomers are known. 
Without limiting the scope of the present invention, 
therefore, the primary focus of the description set forth 
herein will be the separation or enrichment of an enantiomer 
present in a racemic mixture. 
In the process of the present invention, a liquid feed 
mixture is prepared comprising an aqueous solvent, a mix 
ture of at least two optical isomers, and a chiral collector. 
Typically, the aqueous solvent is water, but relatively small 
amounts of water-miscible components (e.g., alcohols, 
tetrahydrofuran, acetonitrile and salts) may be present, so 
long as they do not prevent or interfere with the adsorptive 
bubble fractionation process. 
The chiral collector is a chiral compound which is at least 
partially water soluble and which selectively associates with 
an optical isomer present in the mixture. If the optical isomer 
is not, itself, a surfactant the chiral collector should be a 
surfactant capable of producing bubbles or a foam when 
associating with the optical isomer as a gas is bubbled 
through the solution. Enantioselectivity (or 
diastereomerselectivity) could result either from a difference 
in the association energy between the chiral collector and the 
two enantiomers (or diastereomers), from a difference in the 
surface adsorption of the two diastereomeric (chiral collec 
tor plus enantiomer or diastereomer) complexes, or from 
some combination of these two factors. 
The chiral collectors interact with the optical isomer via 
a combination of ligand exchange interactions, charge 
charge interactions, dipolar interactions, it interactions, 
steric interactions, hydrophobic interactions, hydrogen 
bonding interactions, or other types of interactions known to 
those of ordinary skill. As such, the chiral collectors have 
functional groups or a structure which provide at least three 
points of interaction with the optical isomer of interest. The 
points of interaction may be provided, for example, by (i) 
hydrogen-bonding groups such as carbonyl, hydroxyl, 
amine, sulfoxide and amide groups, with hydroxyl and 
amine groups being the presently preferred hydrogen 
bonding groups, (ii) acidic groups such as carboxylates, 
sulfonates, sulfates, phosphates, phosphonates, 
phosphenates, and phenolates with carboxylic acids being 
the presently preferred acidic groups, (iii) basic groups such 
as protonated amines which include, for example, ammo 
nium and alkyl and aryl ammonium groups, (iv) dipolar 
interactive groups such as carbonyl, amide, and sulfonamide 
groups, (v) aromatic rings (carbo- or heterocyclic, substi 
tuted or unsubstituted) which provide TC interaction with the 
optical isomer of interest, and (vi) a hydrophobic region 
consisting of one or more non-polar moieties located in 
close proximity to one another such as a hydrophobic cavity, 
i.e., a region of the chiral collector which is generally 
concave in shape (when viewed in three dimensions), is 
more hydrophobic than the solution in which the chiral 
collector is dissolved, and is capable of forming a complex 
with the isomer of interest. 
In a preferred embodiment of the present invention, the 
chiral collector has a sufficient number of the requisite 
groups or moieties and in the proper orientation such that 
simultaneous interactions can occur with chiral molecules. 
Also, the chiral collector should be surface-active for most 
separations. Chiral collectors falling within this class 
include many derivatized cyclodextrins, amino acids (native 
or derivatized), antibiotics (native or derivatized), proteins 













carbohydrates (native or derivatized), crown ethers, spe 
cially designed synthetic compounds and combinations 
thereof. In this context, derivatization means attachment of 
a functional group or moiety which (i) provides one or more 
points of interaction as described in detail in the paragraph 
immediately preceding this paragraph, or (ii) modifies or 
introduces surface-activity. 
In general, the amount of chiral collector in the liquid feed 
mixture should be sufficient to create a continuous foam. In 
addition, the chiral collector is preferably present in a molar 
excess relative to the optical isomer with the molar ratio of 
the two being in the range, for example, of about 1:1 to about 
5:1 (collector:isomer). Large molar excesses of the collector (e.g., >10:1) can result in a diminishing enrichment or yield 
and are presently not preferred. 
Adsorptive bubble separation is effected by passing a gas 
through a pool of the liquid mixture. The gas should be 
essentially inert with respect to the components of the feed 
mixture. Typically, air or nitrogen may be used. 
On passing of the gas through the feed mixture, bubbles 
are formed and a layer of surfactant collects at the gas liquid 
interface on the bubble surfaces. As previously noted, the 
surfactant may be the chiral collector or the optical isomer. 
In either event, the chiral collectorinteracts with at least one 
of the optical isomers in the mixture and the interacting pair 
become adsorbed on the bubble surfaces. As a result of the 
selectivity of the chiral collector for one of the optical 
isomers or as a result of different surface adsorption 
characteristics, one optical isomer is preferentially adsorbed 
on the bubble surfaces. This has the effect of concentrating 
at least one of the optical isomers in the foam and at least one 
of the optical isomers in the liquid feed mixture, either of 
which may be the isomer of interest. 
Where optical isomer separation is effected by bubble 
fractionation, passage of bubbles up through the liquid 
mixture results in concentration of one of the optical isomers 
of the mixture in a layer at the upper surface of the liquid, 
while in foam fractionation, that isomer is transported from 
the liquid by foam rising from the upper liquid surface. 
Preferably, foam fractionation is employed and the foam 
which rises from the upper liquid surface is separated from 
the liquid mixture. If the optical isomer of interest is 
concentrated in the foam, it is then collected by collapsing 
the separated foam at a location other than the liquid surface 
and separating the chiral collector from the isotope of 
interest by liquid-liquid extraction, precipitation by 
evaporation, or other standard techniques known to those of 
ordinary skill. It is preferred that the chiral collector have a 
different solubility than the optical isomer (in water or 
organic solvent), different partitioning characteristics or a 
different volatility to readily enable separation of the chiral 
collector from the isomer. Also, it is preferred that the chiral 
collector be stable through the fractionation and separation 
steps of the present invention to enable recycle and reuse of 
the chiral collector. 
Although temperature of operation is not narrowly 
critical, lower operating temperatures generally provide 
greater selectivity. Depending upon the selectivity, 
therefore, the process may be carried out at room tempera 
ture. For some systems, however, selectivity at room tem 
perature will be insufficient and temperatures of about 10°C. 
or less are preferred. 
Illustrated schematically in FIG. 1 is an apparatus for 
separation of optical isomers by foam fractionation. The 
apparatus, generally designated by reference numeral 10 
comprises a column 12 disposed over a vessel 14. Within 
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vessel 14 is a pool 16 of the liquid mixture which comprises 
a chiral collector and two or more optical isomers to be 
separated. Gas is introduced into pool 16 through a sparger 
18 (such as a fine, porous glass frit) creating bubbles which 
pass through the pool and form a foam phase 20 above the 
upper surface of pool 16. The foam preferably consists of 
bubbles having an average diameter of less than about 5 
millimeters, more preferably less than about 3 millimeters, 
and even more preferably less than about 1 millimeter. Foam 
20 moves upward into column 12, contacts packing material 
22 and then through a U-bend 24 into foam beaker 26 where 
the foam is collapsed by allowing it to rest, adding a miscible 
or immiscible solvent, heating or other conventional tech 
niques. The packing material may be any conventional, inert 
packing material such as glass metal or plastic beads, helices 
or coils which increase the surface area of the column and 
assist in controlling the flow rate of the foam, thereby 
reducing the size of the foam bubbles and the water content 
of the foam. Gas is fed to sparger 18 through tube 28. 
Preferably, the gasflow rate is initially adjusted so that the 
foam remains equilibrating in the column under reflux 
conditions for several minutes, e.g., about 5 to about 30 
minutes. During this period, foam is rising from the liquid 
surface and passing through the packing material. 
Simultaneously, bubbles in the rising foam break thereby 
releasing liquid which flows back down through the packing 
material and into the pool. 16. This countercurrent process is 
analogous to total reflux conditions in a fractional distilla 
tion column. After this initial period, the gas flow rate is 
increased and foamed solution is collected in foam beaker 
26. During the period in which foam is being collected, 
however, partial reflux of the mixture continues with the 
volume ratio of liquid moving up the column as a foam to 
liquid draining toward the pool preferably being at least 
about more preferably at least about 1:1, and still more 
preferably at least about 5:1, 10:1, 50:1 or even 100:1. 
The optical isomer of interest may be found in the 
overhead product or in pool upon cessation of the bubbling 
as a bottoms product. If desired, the process may be repeated 
using the overhead or the bottoms product as the starting 
solution. 
The following example will illustrate the invention. 
EXAMPLE 
In this example, enantiomeric enrichments were obtained 
for each of two different compounds using the foaming 
device used shown in FIG. 1 in which the foam column was 
32 cm long, the glass beads were 0.7 cm diameter, the 
sample chamber could hold up to 200 ml of aqueous sample 
solution, and the gas flow rate (i.e., N, or air) was controlled 
via a flow control valve. The structures of the racemic 












NO2 O CH 
1 CH 
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H (SQ30,840) 
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CH N O 
h (SQ31,236) 
Stock solutions of the compounds were made into stock 
solutions in ethanol (or in acetonitrile for those analytes 
analyzed using vancomycin) at a concentration of 12 
mg/mL). Solutions of the chiral collector were made in 
distilled water or buffer at concentrations ranging from 
0.01% to 1%. One milliliter of the racemic mixture solution 
and 19 mL of chiral collector solution were placed into the 
foaming chamber, and the foaming column was attached to 
the sample chamber via a ground-glass joint. Air was used 
to generate bubbles from the bottom of the chamber. The 
height of the foamin the column was controlled by adjusting 
the air flow rate with a fine control valve. In general, dry 
foam formed after a period of controlled reflux gives the best 
results. The glass beads also seem to help produce a finer, 
slower rising foam. The foam bubbles tend to break on the 
way up the column thereby producing a thin film of liquid 
that flows down the column (i.e., opposite to the foam 
migration). The airflow rate was adjusted so that a steady 
countercurrent condition was produced (somewhat analo 
gous to that of a fractional distillation column). At this point 
nofoam passes to the receiver. Afoam fraction was collected 
either by slightly increasing the flow rate to force some foam 
into one receiver or by using a syringe connected to a long 
thin Teflon tube on the needle to reach the top layer of the 
foam in the column. In some experiments, 3 mL of a foam 
fraction and 12 mL of fresh chiral collector solution were 
used for a series of consecutive runs. Most enantiomeric 
ratios in the foam fractions were determined by HPLC. A 
Shimadzu LC6A liquid chromatography with a variable 
wavelength detector and a C-R3AChromatopac data system 
were used for all data analysis. The chromatographic con 
ditions for the separation of all compounds studied are listed 
in Table 1. The UV detection wavelength was 254 nmfor all 
analytes except for the N-t-BOC amino acids, which was 
225 nm. The warfarin peaks overlapped with the chiral 
collector, thus solid phase extraction on a silica cartridge 
was employed to remove the chiral collector before HPCL 
injection. The silica cartridge was washed with 3-5 mL of 
diethyl ether before the warfarin fraction was loaded, and 
then warfarin was eluted from the cartridge with diethyl 
ether and collected for analysis. Foam fractions of other 
compounds were injected directly on the chiral stationary 
phase containing LC column. The enantiomeric purity of 
dansyl-tryptophan and dansyl-phenylalanine were deter 
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mined directly on a Waters Quanta 4000 CE apparatus as the chiral selector. 
equipped with a 254 nm lamp and a 50 um (i.d.)X32 cm (24 
TABLE 1. 
8 
cm to detector) fused silica capillary. The run buffer con 
tained 0.1M, pH 6 phosphate buffer plus 2 mM vancomycin 
Analytical Separation Conditions for Enantiomeric Excess Determinations 
Racemate Structure Column Mobile Phase' or Run Buffer 
warfarin Cyclo- acetonitrile/methanol/acetic acid/ 
bond I triethylamine (90/10/0.004/0.004) 





H N CH3 
H 
SQ 31,236 NO2 Cyclo- aqueous buffer/acetonitrile (85/15) 
bond 
ISPd 
Clu H. C N1No1 N-COOCH(CH3)2 
HC N 1so 
H 




N-t-Boc-phenyl- CO2H Cyclo- aqueous bufferlacetonitrile (93/7) 
alanine bond 
CH-CH-NH-CO2-C(CH3)3 IRSPC 
leucine COOH Cyclo- acetonitrile/methanol/acetic acid/ 
bond I triethylamine (90/10/04/2) H2N-CH-CH-CH(CH3)2 
methionine COOH Cyclo- acetonitrile/methanol/acetic acid/ 
bond I triethylamine (96/4/0.6/1) H2N-CH-CH2-CH2-S-CH3 
phenylalanine' CO2H Cyclo- acetonitrile/methanol/acetic acid/ 





Analytical Separation Conditions for Enantiomeric Excess Determinations 
Racemate Structure Column Mobile Phase or Run Buffer 
tryptophan" N Cyclo- acetonitrilelmethanol/acetic acid/ 
bond I triethylamine (96/4/06/1.2) 
COOH 
H2N -h -CH2 
COOH 
dansyl-tryptophan fused 0.1Mphosphate buffer (pH 6) containing 




dansyl- fused 0.1Mphosphate buffer (pH 6) containing 





Before analysis these amino acids were derivatized with AQC; fluorescent tagging agent. See S. Armstrong et al., Journal of Analytical Chem, Vol. 62, 914 (1990) for the complete procedure. 
Cyclobond I refers to a 25 cm (4.6 cm i.d.) native B-cyclodextrin HPLC column. 
Cyclobond IRSP refers to a 25 cm (4.6 cm i.d.) rac-hydroxypropyl-3-cyclodextrin HPLC column. 
Cyclobond ISP refers to a 25 cm (4.6 cm i.d.) (S)-hydroxypropyl-B-cyclodextrin HPLC column. 
This column is a 50 m (i.d.) X 32 cm (24 cm to detector) fused silica capillary used in capillary electrophoresis. 
Mobile phase compositions are given as volume ratios. 
The buffer consisted of 1% triethylammonium acetate (aq), pH 4.1. 
The buffer consisted of 1% triethylammonium acetate (aq), pH 7.1. 
General conditions for the alkylhydroxyproline and digi 
tonin chiral collector experiments were as follows: 5mL of 
0.02% (unless indicated otherwise) surfactant solution 
(n-heptyl-L-hydroxyproline, for example) in water was 
mixed with 0.25 mL of stock solutions of leucine (2 
mg/mL), methionine (2.32 mg/mL), phenylalanine (2.6 
mg/mL), and tryptophan (2.8 mg/mL). Approximately 4.4 
mg of cupric acetate was added to the solution. When 
foaming was completed, the residual solution was analyzed 
as outlined below. All amino acids were derivatized with 
(6-aminoquinolyl)-N'-hydroxysuccinimidyl carbamate 
(AQC) and separated via HPLC as indicated in Table I. This 
achiral derivatization procedure for amino acids and the 
enantioselective separation method has been described pre 
viously. 
A Small aliquot of this sample was analyzed (by chiral 




meric ration of the test solute. Nine additional milliliters of 
foam solution was then taken. The total solution (12 ml) was 
transferred to an identical foaming device for the next cycle. 
Using this procedure we were able to start with racemic SQ 
30840 and achieve a solution containing 81% of one enan 
tiomer vs 19% of the other. In the case of SQ31236 a 2:1 
enantiomeric enhancement was found. 
Enantiomeric enrichment conditions and results using 
various derivatized cyclodextrins, alkylated amino acids, 
digitonin, and some antibiotics are set forth in Tables 2 and 
3. Table 2 summarizes the data for different derivatized 
cyclodextrin chiral collectors while Table 3 does the same 
for other chiral collectors. Note that the alkylproline chiral 
collectors (Table 3) were used in a "ligand exchange” 
format. Hence, copper (II) salts were dissolved in solution 
before foaming. 
TABLE 2 
Foam Flotation Conditions and Enantiomeric Enrichments Using Derivatized Cyclodextrin Collectors 
Collector foaming No. Passes 
Concentration temp column through enantioneric ee 
Racemates Collectors (G/100 mL) (°C) ht (cm) column ratio (%) 
warfarin PM-3-CD 1. 23 25 1. 640 20 
DM-B-CD 1. 23 25 1. 44/56 2 




Foam Flotation Conditions and Enantiomeric Enrichments. Using Derivatized Cyclodextrin Collectors 
Collector foaming No. Passes 
Concentration temp column through enantiomeric ee 
Racemates Collectors (G/100 mL) (°C) ht (cm) column ratio (%) 
HP-B-CD 1 23 25 1. 66/34 32 
SQ 31,236 HP-B-CD 1. 23 25 1. 46/54 8 
N-t-BOC-chlorophenylalanine PM-3-CD 0.05 23 25 1. 47/53 6 
PM-B-CD 0.05 4. 25 1. 37/63 26 
N-t-BOC-phenylalanine PM-B-CD 0.05 23 25 1 41159 18 
PM-B-CD 0.05 4 25 1. 18/82 64 
PM-B-CD O.05 4. 40 1. 1288 76 
DM-B-CD 0.05 4. 25 1. 48/52 4 
Abbreviations: PM-B-CD = heptakis-2,3,6-tri-O-methyl-8-cyclodextrin; DM-B-CD = heptakis-2,6-di-O-methyl-8-cyclodextrin; Oct 
BSP = a mixture of 8-cyclodextrin monoctyl and dioctyl esters; HP-8-CD = hydroxypropyl-B-cyclodextrin. is is the peak area ratio of first peak/second peak. 
Enantiomeric excess (ee) is defined as follows: ee = ((E-E)(E+E)) x 100%, where E is the amount of the enantiomer present 
in higher concentrations and E is the amount of the enantiomer present in lower concentration. 
TABLE 3 
Foam Flotation Conditions and 
Enantiomeric Enrichments. Using Chiral Collectors Not Related to Cyclodextrin 
Collector foaming No. Passes 
Concentration temp column through enantiomeric ee 
Race mates Collectors (G/100 mL) (°C.) ht (cm) column ratio (%) 
leucine Hep-HProl 0.4 23 25 35165 30 
Dodec-HProl std soln 23 25 1. 46/54 8 
methionine Hep-Hprol 0.2 23 25 1. 4258 16 
phenylalanine Hep-HProl 0.2 23 25 1 41159 18 
tryptophan digitonin atd soln 23 25 1. 4T153 6 
dansyl-tryptophan vancomycin 0.06 4 25 1. 41159 18 
dansyl-phenylalanine vancomycin 0.06 4. 25 1. 47153 6 
Abbreviations: Hep-HProl = n-heptyl-L-hydroxyproline; Dodec-HProl = n-dodecyl-L-hydroxyproline. 
This is the peak area ratio of first peak/second peak. 
Enantiomeric excess (ee) is defined as follows: ee = (E - E2)/(E + E2) x 100%, where E is the amount of the enantioner 
present in higher concentration and E is the amount of the enantiomer present in lower concentration. 
A number of things are evident from the data presented in 
Tables 2 and 3. First and foremost, it is clearly demonstrated 
that enantiomeric enrichments are possible using adsorptive 
bubble processes. While enantiomeric enrichments after a 
single pass through the column at room temperature (ee's= 
4–30) are not extraordinary, they are easily enhanced by 
modifying certain experimental conditions. As can be seen 
in Table 2 for N-t-BOX-chlorophenylalanine and N-t-BOC 
phenylalanine, lowering the temperature of the foam flota 
tion column and sample reservoir to 4° C. results in a 
significant increase in the enantiomeric excess. Increasing 
the length of the foam column from 25 to 40 cm also 
appeared to enhance the effectiveness of the separation 
(Table 2 and FIG. 2). The results for warfarin were particu 
larly interesting. This was because enrichments were pro 
duced with two different cyclodextrin derivatives but they 
gave opposite enantiomeric selectivity (FIG. 3 and Table 2). 
This was the only case where an enantioselective reversal 
was observed. Enantiomeric enrichments also can be 
enhanced by repeating the foam fractionation process with a 
series of identical devices. 
It appears that there are some similarities between the 
operation of a foam fractionation column and a fractional 
distillation column. For example, longer columns (Table 2) 
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and additional fractionation cycles (Tables 4 and 5) give a 
more highly enriched product. The best results are obtained 
in both systems when the columns are operated under 
"reflux' conditions (where there is a countercurrent flow in 
the column). As shown in FIG. 4, allowing the foam system 
to equilibrate or reflux for a period of time (before sample 
removal) enhances the enrichment process. However, after 
this particular system has equilibrated for a period of time 
(-25-90 min), there is no benefit (i.e., no further 
enrichments) in extending the process. 
TABLE 4 
Effect of Repeated Passes Through a Foam Flotation 
Column on the Enantiomeric Emrichment of SQ30 840 
Cycle Number 
Peak Area 1 2 3 4. 5 6 7 8 
First Peak 2.31 2.44 1.39 1.22 1.18 1.23 0.82 0.68 
Second Peak 2.08 155 0.76 0.56 0.55 0.44 0.24 0.16 
Peak Ratio 1.11 1.61 1.83 2.18 2.15 2.80 3.42 4.25 
Hydroxypropyl-3-cyclodextrin was used as the chiral collector (See Experi 




Effect of Repeated Passes Through a Foam Flotation 
Column on the Enantiomeric Enrichment of SQ 31,236 
Cycle Number 
Peak Area 1. 2 3 4 5 6 
First Peak 3.61 2.66 1.97 148 1.22 0.64 
Second Peak 4.26 3.42 2.66 2.16 255 1.43 
Peak Ratio 1.18 1.28 1.35 146 2.09 2.23 
Hydroxypropyl-B-cyclodextrin was used as the chiral collector (See Experi 
mental Section and Table II for further experimental details. 
FIG. 4 also shows that the concentration of the chiral 
collector affects the enantiomeric enrichment. There appears 
to be an optimum concentration of chiral collector and 
racemate for every system. The enantiomeric excess 
decreases if the systemis operated with too much or too little 
chiral collector. The optimum concentrations of chiral col 
lector and racemate must be determined empirically. As yet 
we have found no recognizable trend or theory that allows 
a prediction of the best absolute and/or relative concentra 
tions. Another factor that affects the enantiomeric excess is 
the pH of the sample solution. FIG. 5 indicates that L-N-t- 
BOC-phenylalanine is more highly enriched at pH's near 3 
than at more basic pH's. This is not surprising in view of 
past enantioseparation results in reversed phase HPLC. The 
pH controls the ionization state of the analyte and in some 
cases of the chiral selector. Consequently, enantioselective 
interactions are strongly pH dependent. It is not unusual in 
HPLC and capillary electrophoresis for an enantiomeric 
separation to occur at one pH and not at another. Clearly, 
optimization of the pH can be as important in foamflotation 
as in most other water-based enantioseparation techniques. 
In general, factors that appeared to affect this water-based 
separation include the following: (a) column length, (b) 
column geometry and packing, (c) gas flow rate, (d) column 
geometry and packing, (c) gas flow rate, (d) concentration of 
the chiral collector and the racenate, (e) nature of the chiral 
collector, (f) temperature, (g) pH, (h) reflux time, (i) foam 
dryness, and (j) the presence of other materials in the sample 
(e.g., miscible organic solvents, salts, etc.). 
Materials. Heptakis(2,6-di-O-methyl)-3-cyclodextrin was 
purchased from Sigma (St. Louis, Mo.), permethyl-3- 
cyclodextrin was obtained from Cyclolab R&D Laboratory (Budapest, Hungary), and hydroxypropyl-3-cyclodextrin 
was obtained from Consortium. FurElektrochemische Indus 
trie GMBH. Significantly, no commercial derivatized cyclo 
dextrins are pure; they are composed of mixtures of homo 
logues and isomers. Warfarin, D- and L-N-t-BOC 
phenylalanine, D- and L-N-t-BOC-chlorophenylalanine, 
dansyl-D.L-tryptophan, dansyl-D,L-phenylalanine, 
N-heptyl-L-hydroxyproline, Vancomycin, and digitonin 
were purchased from Sigma. SQ30,840 and SQ31.236 were 
obtained from Squibb (New Brunswick, N.J.). All solvents 
were obtained from Fisher Scientific (Fair Lawn, N.J.). The 
silica cartridges for solid phase extraction were purchased 
from Alltech (Deerfield, Ill.). All HPLC columns were 
obtained from Advanced Separation Technology Inc. 
(Whippany, N.J.). Pyrex gas dispersion tubes and other 
glassware were obtained from Fisher Scientific. 
In view of the above, it will be seen that the several 
objects of the invention are achieved. 
As various changes could be made in the above compo 
sitions and processes without departing from the scope of 
the invention, it is intended that all matter contained in the 














What is claimed is: 
1. A process for enriching the concentration of an enan 
tiomer or a diastereomer in a mixture of optically active 
isomers, the process comprising: 
preparing a solution containing the mixture of the opti 
cally active isomers and a chiral collector in which the 
chiral collector and the enantiomer or diastereomer are 
associated with each other, 
bubbling a gas through a pool of the solution to form a 
foam, the surfaces of the bubbles in the foam having the 
chiral collector and the enantiomer or diastereomer 
preferentially adsorbed thereto so that the concentra 
tion ratio of the optically active isomers at said bubble 
surfaces differs from that in the bulk of the pool, 
moving said foam vertically through a column above the 
pool such that during said movement at least a portion 
of the bubbles comprising the foam break thereby 
allowing liquid to drain toward the pool to provide an 
internal reflux within the column. 
2. The process of claim 1 wherein the column is packed 
with a packing material. 
3. The process of claim 1 wherein the column is packed 
with glass, plastic or metal spheres, helices or coils. 
4. The process of claim 1 wherein the foam exits the 
column and is collected as an overhead product and, as the 
foam exits the column, the volume ratio of liquid moving up 
the column as a foam to liquid draining toward the pool is 
at least about 1:5. 
5. The process of claim 1 wherein the foam exits the 
column and is collected as an overhead product and, as the 
foam exits the column, the volume ratio of liquid moving up 
the column as a foam to liquid draining toward the pool is 
at least about 1:1. 
6. The process of claim 1 wherein the foam exits the 
column and is collected as an overhead product and, as the 
foam exits the column, the volume ratio of liquid moving up 
the column as a foam to liquid draining toward the pool is 
at least about 5:1. 
7. The process of claim 1 wherein the foam exits the 
column and is collected as an overhead product and, as the 
foam exits the column, the volume ratio of liquid moving up 
the column as a foam to liquid draining toward the pool is 
at least about 10:1. 
8. The process of claim 1 wherein the foam exits the 
column and is collected as an overhead product and, as the 
foam exits the column, the volume ratio of liquid moving up 
the column as a foam to liquid draining toward the pool is 
at least about 50:1. 
9. The process of claim 1 wherein the foam exits the 
column and is collected as an overhead product and, as the 
foam exits the column, the volume ratio of liquid moving up 
the column as a foam to liquid draining toward the pool is 
at least about 100:1. 
10. A process for enriching the concentration of an 
enantiomer in a mixture of optical isomers, the process 
comprising: 
preparing a solution containing the mixture of the opti 
cally active isomers and a chiral collector in which the 
chiral collector and the enantiomer are associated with 
each other and in which there are simultaneously at 
least 3 points of interaction between the chiral collector 
and the enantiomer, 
bubbling a gas through a pool of the solution to form 
bubbles, the surfaces of the bubbles having the chiral 
collector and the enantiomer preferentially adsorbed 
thereto so that the concentration ratio of the optical 
isomers at said bubble surface differs from that in the 
bulk of the pool, and 
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moving said bubbles vertically through the area above the 
upper surface of the pool. 
11. The process of claim 10 wherein the chiral collector 
has surface-active properties. 
12. The process of claim 10 wherein after said moving 
step, the bubbles are recovered as an overhead product 
containing a mixture of optical isomers which is enriched in 
one of the enantiomers as compared to the starting solution, 
the bubbles in the overhead product are collapsed, and the 
fractionation process of claim 1 is repeated using a solution 
which is prepared from the overhead product. 
13. The process of claim 12 wherein the process of claim 
12 is repeated at least once. 
14. The process of claim 10 wherein after said moving 
step, the pool is recovered as a bottoms product containing 
a mixture of optical isomers which is enriched in one of the 
enantiomers or diastereomers as compared to the starting 
solution, and the fractionation process of claim 1 is repeated 
using a solution which is prepared from the bottoms product. 
15. The process of claim 14 wherein the process of claim 
14 is repeated at least once. 
16. A process for enriching the concentration of an 
enantiomer in a mixture of optically active isomers, the 
process comprising: 
preparing a solution containing the mixture of the opti 
cally active isomers and a chiral collector in which the 
chiral collector and the enantiomer are associated with 
each other and in which there are simultaneously at 
least 3 points of interaction between the chiral collector 
and the enantiomer with one of the points of interaction 







bubbling a gas through a pool of the solution to form a 
foam, the surfaces of the bubbles of the foam having an 
inclusion complex of the chiral collector and the enan 
tiomer preferentially adsorbed thereto, so that the con 
centration ratio of the optically active isomers at said 
bubble surfaces differs from that in the bulk of the pool, 
and 
moving said foam vertically through the gas-space above 
the upper surface of the pool. 
17. A process for enriching the concentration of an 
enantiomer or a diastereomer in a mixture of optically active 
isomers, the process comprising: 
preparing a solution containing the mixture of the opti 
cally active isomers and a chiral collector in which the 
chiral collector and the enantiomer or diastereomer are 
associated with each other, 
bubbling a gas through a pool of the solution to form 
bubbles, the surfaces of the bubbles having the chiral 
collector and the enantiomer or diastereomer preferen 
tially adsorbed thereto so that the concentration ratio of 
the optically active isomers at said bubble surface 
differs from that in the bulk of the pool, 
moving said bubbles vertically through the gas-space 
above the upper surface of the pool, and 
thereafter recovering the optical isomer of the mixture 
from the pool which is present in the greatest quantity. 
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